NCT01699867View on ClinicalTrials.gov

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

April 30, 2014

Conditions
Breast Cancer
Interventions
DEVICE

Optical coherence tomography

Optical coherence tomography was used to image ex vivo breast tissue specimens.

Trial Locations (2)

21231

Johns Hopkins Hospital, Baltimore

21401

Anne Arundel Medical Center, Annapolis

Sponsors
All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

lead

Diagnostic Photonics, Inc.

INDUSTRY